SOPHiA DDM™
for Genomics

Achieve best-in-class accuracy for your genomic analysis
Accelerate confident decision-making in Oncology and Rare & Inherited Disorders with end-to-end genomics workflows for streamlined sequencing data analysis and interpretation. Reach accurate variant detection, simplified variant prioritization, and expedited reporting. 
Request a Demo
Home breadcrumb-arrow SOPHiA DDM™ for Genomics

Overcome bottlenecks and increase confidence in your results

SOPHiA DDM is a leading IVDR-certified* genomics platform that leverages AI algorithms to accurately pinpoint signals within noisy, complex next-generation-sequencing (NGS) datasets. It seamlessly integrates into any genomics workflow to identify causative variants.

*When used in Dx mode
Best-in-class accuracy
Detect challenging variants with high confidence using our AI/machine learning algorithms, which excel at calling complex and diverse variant types.
Universal compatibility
Effortlessly integrate our technology-agnostic analytical platform into your existing laboratory setup for any Oncology or Rare & Inherited Disorder application.
Accelerated workflows

Dramatically expedite your interpretation by removing genomic variant analysis barriers with the SOPHiA DDM’s annotation and pre-classification capabilities.

Democratizing
data-driven medicine

Improve accuracy

Utilize robust AI-powered algorithms to derive deep insights from complex data.

Expedite turnaround times

Utilize robust AI-powered algorithms to derive deep insights from complex data.

Accelerate adoption of precision medicine

Utilize robust AI-powered algorithms to derive deep insights from complex data.

Optimize resources

Utilize robust AI-powered algorithms to derive deep insights from complex data.

Accelerate adoption of precision medicine

Utilize robust AI-powered algorithms to derive deep insights from complex data.

From data to decisions, faster than ever

Securely log in to our cloud-based platform with 2-step verification. Quickly upload FASTQ files and select from performance pipelines tailored to sample type, chemistry, enrichment kit, and sequencer.
Assess multiple variant types within a single experiment without needing deep bioinformatics expertise. Our somatic and germline pipelines are optimized for targeted to genome-sized applications and provide comprehensive annotation with up-to-date information from >55 world-renowned curated databases, guidelines, and predictors.
Leverage machine learning and guideline-driven ranking to automatically assign pathogenicity levels to identified variants. Through our user-friendly interface, easily apply multiple filtering functions to focus on disease-specific variants, create custom filtering strategies, and/or filter by inheritance mode.
Utilize robust AI-powered algorithms to derive deep insights from complex data.

Add context to your variant interpretation. Flag variants and share insights with your disease-specific peer network or the entire SOPHiA GENETICS Community. Enhance your interpretation with direct access to the add-on modules OncoPortal™ and Alamut™ Visual Plus, that provide deeper, more comprehensive insights into your findings.

Easily generate customized reports using provided templates. Reports are CAP- and CLIA-compliant and include guideline-driven information to support decision making.
Securely log in to our cloud-based platform with 2-step verification. Quickly upload FASTQ files and select from performance pipelines tailored to sample type, chemistry, enrichment kit, and sequencer.

Universally compatible, infinitely powerful

There are three ways to leverage the power of SOPHiA DDM™ in your institution, depending on your unique capabilities and requirements.
ICON
DRY LAB
Dry lab
Process samples with your in-house consumables and instruments, then accurately and securely analyze your data with the SOPHiA DDM™ Platform for rapid, community-powered insights.
ICON
BUNDLE
Bundle
Achieve precise results in your institution with SOPHiA DDM™ sample-to-report applications, including library preparation consumables and tailored analytics for streamlined workflows.
ICON
DRY LAB
Integrated
Connect with certified sequencing partners through SOPHiA DDM™ Integrated Access Mode, while maintaining full control of your data uploaded to SOPHiA DDM™ for analysis.
Download Flyer

SOPHiA DDM™ in action

Watch how you can streamline your genomics workflow during this 4-minute tutorial video that walks through the key user-friendly features of SOPHiA DDM™ for variant analysis and interpretation.

Praesent quis aliquam quam. Maecenas eros nulla, luctus sed leo vel, congue cursus ex. Maecenas ac erat quis felis rhoncus euism
Request a Demo

SOPHiA DDM™ is CE marked under IVDR

IVDR certification validates the powerful analytical capabilities of the
SOPHiA DDM™ Platform for supporting patient diagnostics in the EU and beyond*. SOPHiA DDM is a single platform supporting IVD and RUO applications. Certification provides proof of compliance with regulatory requirements, reducing the burden for healthcare institutions when implementing in vitro diagnostic workflows.

*When used in Dx mode.

Learn More

Conquer new summits in data-driven medicine

There are three ways to leverage the power of SOPHiA DDMTM in your lab, depending on your unique capabilities and requirements.
ICON
DRY LAB
Global community
Join one of the largest global networks of healthcare institutions to securely and anonymously share knowledge with your peers and confidently assess even challenging variants.
ICON
BUNDLE
Unrestricted scalability
Benefit from a modular, web-based platform architecture enhanced by NVIDIA GPUs, enabling seamless adaptation to new technologies and increasingly larger datasets.

ICON
DRY LAB
Robust data security
Rely on the highest standards of data privacy and cloud security with full compliance to IVDR, HIPAA, GDPR, and ISO/IEC 27001, 27017 & 27018.
Download Flyer

Heading for References lorem ipsum

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview
Unlocking Insights, Transforming Healthcare
Learn About SOPHiA DDM™ 
SOPHiA DDM™ for Genomics

Oncology 

Rare and Inherited Disorders

Add-On Modules

SOPHiA DDM™ for Radiomics
Unlock entirely novel insights from your radiology images
Learn About SOPHiA DDM™ for Radiomics 
SOPHiA DDM™ for Multimodal
Explore new frontiers in biology and disease through novel insights
Learn About SOPHiA DDM™ for Multimodal
Professional Services
Accelerate breakthroughs with our tailored enablement services
Learn About our Professional Services